These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20522597)

  • 1. Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia.
    Yantha J; Tsui H; Winer S; Song A; Wu P; Paltser G; Ellis J; Dosch HM
    Diabetes; 2010 Oct; 59(10):2588-96. PubMed ID: 20522597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of pancreatic glia in type 1 diabetes.
    Tsui H; Chan Y; Tang L; Winer S; Cheung RK; Paltser G; Selvanantham T; Elford AR; Ellis JR; Becker DJ; Ohashi PS; Dosch HM
    Diabetes; 2008 Apr; 57(4):918-28. PubMed ID: 18198358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
    Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
    J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.
    Winer S; Tsui H; Lau A; Song A; Li X; Cheung RK; Sampson A; Afifiyan F; Elford A; Jackowski G; Becker DJ; Santamaria P; Ohashi P; Dosch HM
    Nat Med; 2003 Feb; 9(2):198-205. PubMed ID: 12539039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.
    Rajasalu T; Brosi H; Schuster C; Spyrantis A; Boehm BO; Chen L; Reimann J; Schirmbeck R
    Diabetes; 2010 Aug; 59(8):1966-73. PubMed ID: 20484136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell apoptosis in an accelerated model of autoimmune diabetes.
    Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC
    Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
    Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
    Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
    Lenschow DJ; Ho SC; Sattar H; Rhee L; Gray G; Nabavi N; Herold KC; Bluestone JA
    J Exp Med; 1995 Mar; 181(3):1145-55. PubMed ID: 7532678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.
    Subudhi SK; Zhou P; Yerian LM; Chin RK; Lo JC; Anders RA; Sun Y; Chen L; Wang Y; Alegre ML; Fu YX
    J Clin Invest; 2004 Mar; 113(5):694-700. PubMed ID: 14991067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse.
    Wong S; Guerder S; Visintin I; Reich EP; Swenson KE; Flavell RA; Janeway CA
    Diabetes; 1995 Mar; 44(3):326-9. PubMed ID: 7533734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
    Fife BT; Pauken KE; Eagar TN; Obu T; Wu J; Tang Q; Azuma M; Krummel MF; Bluestone JA
    Nat Immunol; 2009 Nov; 10(11):1185-92. PubMed ID: 19783989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The threshold for autoimmune T cell killing is influenced by B7-1.
    Allison J; Stephens LA; Kay TW; Kurts C; Heath WR; Miller JF; Krummel MF
    Eur J Immunol; 1998 Mar; 28(3):949-60. PubMed ID: 9541590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance.
    Fukaya T; Takagi H; Sato Y; Sato K; Eizumi K; Taya H; Shin T; Chen L; Dong C; Azuma M; Yagita H; Malissen B; Sato K
    Blood; 2010 Sep; 116(13):2266-76. PubMed ID: 20574047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.